Inno Holdings Inc. (INHD) led the latest after-hours scan, gaining approximately 67.4%. The table below ranks the leading qualifying movers captured in the latest snapshot.
Top 10 After-Hours Movers
Scanner snapshot captured 2026-11-18T22:30:03.019Z.
| # | Ticker | Company | Move | Price | Volume | Market Cap |
|---|---|---|---|---|---|---|
| 1 | INHD | Inno Holdings Inc. | +67.4% | $3.85 | 2,538,630 | $5.8M |
| 2 | ACTU | Actuate Therapeutics, Inc. | +23.9% | $0.3042 | 16,320,525 | $14.8M |
| 3 | GMM | Global Mofy AI Limited | +9.4% | $1.70 | 761,917 | $15.1M |
| 4 | ALLO | Allogene Therapeutics, Inc. | +8.0% | $0.7518 | 1,452,812 | $241.1M |
| 5 | INMB | INmune Bio Inc. | +7.8% | $1.11 | 114,225 | $31.9M |
| 6 | BDMD | Baird Medical Investment Holdings Ltd | +7.5% | $0.0850 | 667,219 | $2.5M |
| 7 | IE | Ivanhoe Electric Inc. | +7.0% | $6.40 | 346,327 | $954.6M |
| 8 | FLNA | Filana Therapeutics, Inc. | +6.3% | $0.5795 | 199,777 | $27.4M |
| 9 | ZBAO | Zhibao Technology Inc. | +6.2% | $0.1426 | 142,925 | $1.2M |
| 10 | OFRM | Once Upon a Farm, PBC | +6.2% | $12.08 | 130,750 | $480.8M |
What’s Driving the Moves
INHD — Inno Holdings Inc.
INHD gained approximately 67.4% in the scanner snapshot. A possible catalyst was Inno Holdings Inc. Announces Resumption of Trading on Nasdaq. The headline should be verified against the original source before publication.
ACTU — Actuate Therapeutics, Inc.
ACTU gained approximately 23.9% in the scanner snapshot. A possible catalyst was Actuate Therapeutics Reports Positive Monotherapy Data in Aggressive Melanoma Preclinical Model with Daily Dosing of Elraglusib Oral Tablet at ENA 2026. The headline should be verified against the original source before publication.
GMM — Global Mofy AI Limited
GMM gained approximately 9.4% in the scanner snapshot. A possible catalyst was Global Mofy Announces Indirect Investment in Anthropic as Part of AI Expansion Strategy. The headline should be verified against the original source before publication.
ALLO — Allogene Therapeutics, Inc.
ALLO gained approximately 8.0% in the scanner snapshot. A possible catalyst was Allogene Therapeutics Reports First Clinical Data from Phase 1 RESOLUTION Study of ALLO-329 in Autoimmune Disease. The headline should be verified against the original source before publication.
INMB — INmune Bio Inc.
INMB gained approximately 7.8% in the scanner snapshot. A possible catalyst was INmune Bio (INMB) Q3 2026 Earnings Call Transcript. The headline should be verified against the original source before publication.
BDMD — Baird Medical Investment Holdings Ltd
BDMD gained approximately 7.5% in the scanner snapshot. A possible catalyst was Baird Medical Enters South Korea Market through Strategic Distribution Partnership with ALLIS MED. The headline should be verified against the original source before publication.
IE — Ivanhoe Electric Inc.
IE gained approximately 7.0% in the scanner snapshot. A possible catalyst was Ivanhoe Electric (IE) Misses Estimates, Is It Still 75% Below Fair Value?. The headline should be verified against the original source before publication.
FLNA — Filana Therapeutics, Inc.
FLNA gained approximately 6.3% in the scanner snapshot. A possible catalyst was Filana Therapeutics Names Biopharma Executive Jill M. Quigley to Board. The headline should be verified against the original source before publication.
ZBAO — Zhibao Technology Inc.
ZBAO gained approximately 6.2% in the scanner snapshot. A possible catalyst was Zhibao Technology Reports 16% Revenue Growth to RMB 319.9 Million and Narrows Annual Net Loss by 95.3%. The headline should be verified against the original source before publication.
OFRM — Once Upon a Farm, PBC
OFRM gained approximately 6.2% in the scanner snapshot. A possible catalyst was Popular organic toddler snack recall could cost celebrity-backed food brand $30 million. The headline should be verified against the original source before publication.
What To Watch Next
Premarket and after-hours moves can reverse quickly. Editors should verify the catalyst, filing history, financing activity, float structure and liquidity before publication.

